Anticommensal responses are associated with regulatory T cell defect in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients

Journal of Immunology

Volumn 196, Issue 7, 2016, Pages 2955-2964

  Hetemäki, Iivo ^a   Jarva, Hanna ^a,b   Kluger, Nicolas ^c   Baldauf, Hanna Mari ^a   Laakso, Sini ^a   Bratland, Eirik ^d   Husebye, Eystein S ^d   Kisand, Kai ^e   Ranki, Annamari ^c   Peterson, Pärt ^e   Arstila, T Petteri ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BACTERIUM ANTIBODY; CD45RO ANTIGEN; FUNGUS ANTIBODY; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 22 ANTIBODY; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTICOMMENSAL RESPONSE; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CLINICAL ARTICLE; COMMENSAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; IMMUNE DYSREGULATION; IMMUNOREGULATION; INTESTINE BIOPSY; INTESTINE FLORA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SACCHAROMYCES CEREVISIAE; AUTOIMMUNITY; CASE CONTROL STUDY; DUODENUM; GENETICS; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; POLYENDOCRINOPATHY; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, FUNGAL; AUTOANTIBODIES; AUTOIMMUNITY; CASE-CONTROL STUDIES; CYTOKINES; DUODENUM; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOGLOBULIN G; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84962575619     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500301     Document Type: Article

References (47)

1. Jääskeläinen, J., and J. Perheentupa. 2009. Autoimmune polyendocrinopathycandidosisectodermal dystrophy (APECED)-α diagnostic and therapeutic challenge. Pediatr. Endocrinol. Rev. 7:15-28.
2. Kisand, K., and P. Peterson. 2011. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome. Ann. N. Y. Acad. Sci. 1246:77-91.
3. Heino, M., P. Peterson, J. Kudoh, K. Nagamine, A. Lagerstedt, V. Ovod, A. Ranki, I. Rantala, M. Nieminen, J. Tuukkanen, et al. 1999. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem. Biophys. Res. Commun. 257:821-825.
4. Poliani, P. L., K. Kisand, V. Marrella, M. Ravanini, L. D. Notarangelo, A. Villa, P. Peterson, and F. Facchetti. 2010. Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells. Am. J. Pathol. 176:1104-1112.
5. Suzuki, E., Y. Kobayashi, O. Kawano, K. Endo, H. Haneda, H. Yukiue, H. Sasaki, M. Yano, M. Maeda, and Y. Fujii. 2008. Expression of AIRE in thymocytes and peripheral lymphocytes. Autoimmunity 41:133-139.
6. + T cells. Immunity 39:560-572.
7. Husebye, E. S., J. Perheentupa, R. Rautemaa, and O. Kämpe. 2009. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J. Intern. Med. 265:514-529.
8. Kekäläinen, E., H. Tuovinen, J. Joensuu, M. Gylling, R. Franssila, N. Pöntynen, K. Talvensaari, J. Perheentupa, A. Miettinen, and T. P. Arstila. 2007. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasisectodermal dystrophy. J. Immunol. 178:1208-1215.
9. + precursors and impaired activated population. J. Autoimmun. 35:351-357.
10. +CD25+ T-regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J. Allergy Clin. Immunol. 116:1158-1159.
11. Wolff, A. S., B. E. Oftedal, K. Kisand, E. Ersvaer, K. Lima, and E. S. Husebye. 2010. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scand. J. Immunol. 71:459-467.
12. Pöntynen, N., M. Strengell, N. Sillanpää, J. Saharinen, I. Ulmanen, I. Julkunen, and L. Peltonen. 2008. Critical immunological pathways are downregulated in APECED patient dendritic cells. J. Mol. Med. 86:1139-1152.
13. Ryan, K. R., M. Hong, P. D. Arkwright, A. R. Gennery, C. Costigan, M. Dominguez, D. Denning, V. McConnell, A. J. Cant, M. Abinun, et al. 2008. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED. Clin. Exp. Immunol. 154:406-414.
14. Meager, A., K. Visvalingam, P. Peterson, K. Möll, A. Murumägi, K. Krohn, P. Eskelin, J. Perheentupa, E. Husebye, Y. Kadota, and N. Willcox. 2006. Antiinterferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 3:e289.
15. Kisand, K., A. S. Bøe Wolff, K. T. Podkrajsek, L. Tserel, M. Link, K. V. Kisand, E. Ersvaer, J. Perheentupa, M. M. Erichsen, N. Bratanic, et al. 2010. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 207:299-308.
16. Puel, A., R. Döffinger, A. Natividad, M. Chrabieh, G. Barcenas-Morales, C. Picard, A. Cobat, M. Ouachée-Chardin, A. Toulon, J. Bustamante, et al. 2010. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 207:291-297.
17. Pedroza, L. A., V. Kumar, K. B. Sanborn, E. M. Mace, H. Niinikoski, K. Nadeau, M. Vasconcelos Dde, E. Perez, S. Jyonouchi, H. Jyonouchi, et al. 2012. Autoimmune regulator (AIRE) contributes to Dectin-1-induced TNF-α production and complexes with caspase recruitment domain-containing protein 9(CARD9), spleen tyrosine kinase (Syk), and Dectin-1. J. Allergy Clin. Immunol. 129:464-472.
18. Kluger, N., M. Jokinen, K. Krohn, and A. Ranki. 2013. Gastrointestinal manifestations in APECED syndrome. J. Clin. Gastroenterol. 47:112-120.
19. Prideaux, L., P. De Cruz, S. C. Ng, and M. A. Kamm. 2012. Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm. Bowel Dis. 18:1340-1355.
20. Zhang, Z., C. Li, X. Zhao, C. Lv, Q. He, S. Lei, Y. Guo, and F. Zhi. 2012. Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis. Dig. Dis. Sci. 57:2944-2954.
21. Franke, A., D. P. McGovern, J. C. Barrett, K. Wang, G. L. Radford-Smith, T. Ahmad, C. W. Lees, T. Balschun, J. Lee, R. Roberts, et al. 2010. Genomewide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42:1118-1125.
22. Sartor, R. B. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577-594.
23. Best, W. R., J. M. Becktel, J. W. Singleton, and F. Kern, Jr. 1976. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70:439-444.
24. Ekwall, O., H. Hedstrand, L. Grimelius, J. Haavik, J. Perheentupa, J. Gustafsson, E. Husebye, O. Kämpe, and F. Rorsman. 1998. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352:279-283.
25. Husebye, E. S., G. Gebre-Medhin, T. Tuomi, J. Perheentupa, M. Landin-Olsson, J. Gustafsson, F. Rorsman, and O. Kämpe. 1997. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 82:147-150.
26. + T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J. Clin. Invest. 118:3639-3650.
27. + T cell homeostasis in the monogenic human disease autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Immunol. 187:2023-2030.
28. Peterson, P., J. Perheentupa, and K. J. Krohn. 1996. Detection of candidal antigens in autoimmune polyglandular syndrome type I. Clin. Diagn. Lab. Immunol. 3:290-294.
29. Cohavy, O., D. Bruckner, L. K. Gordon, R. Misra, B. Wei, M. E. Eggena, S. R. Targan, and J. Braun. 2000. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect. Immun. 68:1542-1548.
30. Wei, B., T. Huang, H. Dalwadi, C. L. Sutton, D. Bruckner, and J. Braun. 2002. Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen. Infect. Immun. 70:6567-6575.
31. Ferrante, M., L. Henckaerts, M. Joossens, M. Pierik, S. Joossens, N. Dotan, G. L. Norman, R. T. Altstock, K. Van Steen, P. Rutgeerts, et al. 2007. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56:1394-1403.
32. Söderbergh, A., A. G. Myhre, O. Ekwall, G. Gebre-Medhin, H. Hedstrand, E. Landgren, A. Miettinen, P. Eskelin, M. Halonen, T. Tuomi, et al. 2004. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 89:557-562.
33. Rubino, S. J., K. Geddes, and S. E. Girardin. 2012. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol. 33:112-118.
34. Sonnenberg, G. F., L. A. Fouser, and D. Artis. 2011. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12:383-390.
35. + T cells expressing the FoxP3 transcription factor. Immunity 30:899-911.
36. Dobés, J., A. Neuwirth, M. Dobésová, M. Vobóril, J. Balounová, O. Ballek, J. Lebl, A. Meloni, K. Krohn, N. Kluger, et al. 2015. Gastrointestinal autoimmunity associated with loss of central tolerance to enteric a-defensins. Gastroenterology 149:139-150.
37. Macpherson, A., U. Y. Khoo, I. Forgacs, J. Philpott-Howard, and I. Bjarnason. 1996. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38:365-375.
38. Pitt, L. A., F. X. Hubert, H. S. Scott, D. I. Godfrey, and S. P. Berzins. 2008. NKT cell development in the absence of the autoimmune regulator gene (Aire). Eur. J. Immunol. 38:2689-2696.
39. Kostic, A. D., R. J. Xavier, and D. Gevers. 2014. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146:1489-1499.
40. Antons, A. K., R. Wang, K. Oswald-Richter, M. Tseng, C. W. Arendt, S. A. Kalams, and D. Unutmaz. 2008. Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J. Immunol. 180:764-773.
41. Chauhan, S. K., D. R. Saban, H. K. Lee, and R. Dana. 2009. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J. Immunol. 182:148-153.
42. + cells. J. Immunol. 186:6788-6797.
43. + CD25high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123:79-89.
44. D'Hennezel, E., K. Bin Dhuban, T. Torgerson, and C. A. Piccirillo. 2012. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 49:291-302.
45. Sayar, E., A. Islek, A. Yilmaz, G. O. Elpek, and R. Artan. 2013. Intestinal dysfunction in APECED syndrome could mimic IPEX syndrome. J. Pediatr. Gastroenterol. Nutr. 56:e27.
46. Hardenberg, G., T. S. Steiner, and M. K. Levings. 2011. Environmental influences on T regulatory cells in inflammatory bowel disease. Semin. Immunol. 23:130-138.
47. Posovszky, C., G. Lahr, J. Von Schnurbein, S. Buderus, A. Findeisen, C. Schröder, C. Schütz, A. Schulz, K. M. Debatin, M. Wabitsch, and T. F. Barth. 2012. Loss of enteroendocrine cells in autoimmune-polyendocrine-candidiasisectodermaldystrophy (APECED) syndrome with gastrointestinal dysfunction. J. Clin. Endocrinol. Metab. 97:E292-E300.